Clinical Trial Finder

Inclusion Criteria:

• - Patients with a personal history of cervical cancer with any portion of neuroendocrine component (including mixed tumors) of the following histologic subtypes: - Small cell neuroendocrine carcinoma.

• - Large cell neuroendocrine carcinoma.

• - Undifferentiated high-grade neuroendocrine carcinoma.

• - Patients may be in any stage of treatment, surveillance or recurrence at the time of initial participation in the study.

• - Patients with all stages of disease are considered eligible.

• - Patients who do not speak English can be eligible if accompanied by an institutional interpreter.

• - Patients who are receiving or have received treatment at any facility, including but not limited to M.

D. Anderson Cancer Center are eligible.

• - Patient may be residents of any country and be of any ethnic background.

• - Patients who request to participate in the study, regardless of the method by which they learned of it, are eligible to participate, including, but not limited to patients who seek participation via the website.

• - Next of kin or legal authorized representatives of patients who are deceased but had a history of neuroendocrine carcinoma (NEC) of the cervix are eligible to participate.

• - Next of kin or legal authorized representatives of patients must read and speak English.

Exclusion Criteria:

- Patients with other histologic subtypes of NEC of the cervix including typical and atypical carcinoid tumors

PRIMARY OBJECTIVES:

• I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for patients with neuroendocrine carcinoma of the uterine cervix.

• II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

• III. To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.

OUTLINE: Patients' medical records are reviewed retrospectively and prospectively. Patients are followed up by email, telephone, or United States (U.S.) mail every 4 months for up to 10 years from date of initial study enrollment. Patients, who are beyond 5 years from their initial diagnosis, are followed up by email, telephone, or U.S. mail annually.

Arms

: Observational (medical chart review)

Patients' medical records are reviewed retrospectively and prospectively. Patients are followed up by email, telephone, or U.S. mail every 4 months for up to 10 years from date of initial study enrollment. Patients, who are beyond 5 years from their initial diagnosis, are followed up by email, telephone, or U.S. mail annually.

Interventions

Other: - Follow-Up

Receive follow up

Other: - Medical Chart Review

Review of medical records